醫療平台股榮辱互見 屢探頂藥師幫及醫思健康續漲5%-7% 梅斯健康急吐15%
港股繼昨天整固後,今天重拾升勢,恆指在新經濟股、內房及保險股帶動突破百天線,最高見19,685,現報19,578,回升213點或1.1%,總成交額回升至791億元。此外,恆生科指高見4,357創近四個月高,現報4,316,回升2.3%。
醫療平台股今天榮辱互見。上月28日才以每股20元上市的藥師幫(09885.HK)上周尾公布超額配股權部分獲行使,股價連續第六天創上市新高,最高見49.55元,現報48.9元,續升4.8%。醫思健康(02138.HK)連彈第三天,今天股價升破50天線(4.33元),最高見4.5元,現報4.46元,續升7%。京東健康(06618.HK)及平安好醫生(01833.HK)高見55.4元及19.6元,現報54.3元及19.48元,續升近0.6%-1.3%。
相反,半新股梅斯健康(02415.HK)由上市低位連彈三天累漲21%後,今天股價重失10天線(8.35元),最低見7.37元,現報7.6元,急吐15%。醫脈通(02192.HK)連跌第二天,最低見6.3元,現報6.39元,續跌1.7%。阿里健康(00241.HK)反覆回軟,高低見5.56元/5.35元,現報5.4元,微吐0.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.